Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 5047403, 10 pages
https://doi.org/10.1155/2017/5047403
Research Article

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis

1Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg, Heidelberg, Germany
2Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany
3Dr. von Hauner Children’s Hospital, LMU Munich, Munich, Germany
4Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center, Department of Pediatrics, University Hospital Heidelberg, Heidelberg, Germany
5Department of Translational Pulmonology, University of Heidelberg, Heidelberg, Germany
6Department of Pneumology and Critical Care Medicine, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany

Correspondence should be addressed to Alexander H. Dalpke; ed.grebledieh-inu.dem@ekplad.rednaxela

Received 30 May 2017; Revised 24 August 2017; Accepted 22 October 2017; Published 27 December 2017

Academic Editor: Pierre-Régis Burgel

Copyright © 2017 Sébastien Boutin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Dickson, J. R. Erb-Downward, F. J. Martinez, and G. B. Huffnagle, “The microbiome and the respiratory tract,” Annual Review of Physiology, vol. 78, no. 1, pp. 481–504, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. F. S. Jones, “The source of the microorganisms in the lungs of normal animals,” The Journal of Experimental Medicine, vol. 36, no. 3, pp. 317–328, 1922. View at Publisher · View at Google Scholar
  3. K. L. Whiteson, B. Bailey, M. Bergkessel et al., “The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography,” American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 11, pp. 1309–1315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. R. P. Dickson, J. R. Erb-Downward, C. M. Freeman et al., “Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography,” Annals of the American Thoracic Society, vol. 12, no. 6, pp. 821–830, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Li and Z. (Sam) Ma, “Testing the neutral theory of biodiversity with human microbiome datasets,” Scientific Reports, vol. 6, no. 1, article 31448, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. S. P. Lopes, N. F. Azevedo, and M. O. Pereira, “Microbiome in cystic fibrosis: shaping polymicrobial interactions for advances in antibiotic therapy,” Critical Reviews in Microbiology, vol. 41, no. 3, pp. 353–365, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Faner, O. Sibila, A. Agustí et al., “The microbiome in respiratory medicine: current challenges and future perspectives,” European Respiratory Journal, vol. 49, no. 4, article 1602086, 2017. View at Publisher · View at Google Scholar
  8. S. Boutin, S. Y. Graeber, M. Weitnauer et al., “Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis,” PLoS One, vol. 10, no. 1, article e0116029, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Depner, M. J. Ege, M. J. Cox et al., “Bacterial microbiota of the upper respiratory tract and childhood asthma,” The Journal of Allergy and Clinical Immunology, vol. 139, no. 3, pp. 826–834.e13, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hilty, C. Burke, H. Pedro et al., “Disordered microbial communities in asthmatic airways,” PLoS One, vol. 5, no. 1, article e8578, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Elborn, “Cystic fibrosis,” The Lancet, vol. 388, no. 10059, pp. 2519–2531, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. J. Huang and H. A. Boushey, “The sputum microbiome in chronic obstructive pulmonary disease exacerbations,” Annals of the American Thoracic Society, vol. 12, pp. S176–S180, 2015. View at Google Scholar
  13. M. J. Mammen and S. Sethi, “COPD and the microbiome,” Respirology, vol. 21, no. 4, pp. 590–599, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. K. A. Ramsey, S. Ranganathan, J. Park et al., “Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 10, pp. 1111–1116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. A. Douglas, S. Brennan, S. Gard et al., “Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis,” European Respiratory Journal, vol. 33, no. 2, pp. 305–311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Cox, M. Allgaier, B. Taylor et al., “Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients,” PLoS One, vol. 5, no. 6, article e11044, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. S. Charlson, K. Bittinger, A. R. Haas et al., “Topographical continuity of bacterial populations in the healthy human respiratory tract,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 8, pp. 957–963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. von Mutius, “The microbial environment and its influence on asthma prevention in early life,” The Journal of Allergy and Clinical Immunology, vol. 137, no. 3, pp. 680–689, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. K. De Boeck, N. Derichs, I. Fajac et al., “New clinical diagnostic procedures for cystic fibrosis in Europe,” Journal of Cystic Fibrosis, vol. 10, Supplement 2, pp. S53–S66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. G. Caporaso, C. L. Lauber, W. A. Walters et al., “Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms,” The ISME Journal, vol. 6, no. 8, pp. 1621–1624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. D. Schloss, S. L. Westcott, T. Ryabin et al., “Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities,” Applied and Environmental Microbiology, vol. 75, no. 23, pp. 7537–7541, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. S. Horn, “Measurement of “overlap” in comparative ecological studies,” The American Naturalist, vol. 100, no. 914, pp. 419–424, 1966. View at Publisher · View at Google Scholar
  23. M. I. Love, W. Huber, and S. Anders, “Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2,” Genome Biology, vol. 15, no. 12, p. 550, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. McMurdie and S. Holmes, “Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data,” PLoS One, vol. 8, no. 4, article e61217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Oksanen, F. G. Blanchet, R. Kindt et al., “Vegan: community ecology package. R package 2.0.3,” CRAN R-Proj. Orgpackage Vegan, 2012. View at Google Scholar
  26. H. D. M. Coutinho, V. S. Falcão-Silva, and G. F. Gonçalves, “Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers,” International Archives of Medicine, vol. 1, no. 1, p. 24, 2008. View at Publisher · View at Google Scholar
  27. H. Marchandin, A.-L. Michon, and E. Jumas-Bilak, “Atypical bacteria in the CF airways: diversity, clinical consequences, emergence and adaptation,” Cystic Fibrosis - Renewed Hopes through Research, 2012, InTech. View at Google Scholar
  28. J. B. Lyczak, C. L. Cannon, and G. B. Pier, “Lung infections associated with cystic fibrosis,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 194–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Boutin and A. H. Dalpke, “Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients,” Molecular and Cellular Pediatrics, vol. 4, no. 1, 2017. View at Publisher · View at Google Scholar
  30. L. J. Sherrard, S. C. Bell, and M. M. Tunney, “The role of anaerobic bacteria in the cystic fibrosis airway,” Current Opinion Pulmonary Medicine, vol. 22, no. 6, pp. 637–643, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. P. R. Murray and J. E. Rosenblatt, “Bacterial interference by oropharyngeal and clinical isolates of anaerobic bacteria,” The Journal of Infectious Diseases, vol. 134, no. 3, pp. 281–285, 1976. View at Publisher · View at Google Scholar
  32. F. Di Lorenzo, A. Silipo, T. Matier et al., “Prevotella denticola lipopolysaccharide from a cystic fibrosis isolate possesses a unique chemical structure,” European Journal of Organic Chemistry, vol. 2016, no. 9, pp. 1732–1738, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Park, J. W. Shin, S.-G. Park, and W. Kim, “Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease,” PLoS One, vol. 9, no. 10, article e109710, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Pérez-Losada, E. Castro-Nallar, M. L. Bendall, R. J. Freishtat, and K. A. Crandall, “Dual transcriptomic profiling of host and microbiota during health and disease in pediatric asthma,” PLoS One, vol. 10, no. 6, article e0131819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Tlaskalová-Hogenová, R. Štěpánková, T. Hudcovic et al., “Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases,” Immunology Letters, vol. 93, no. 2-3, pp. 97–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Ratner and C. Mueller, “Immune responses in cystic fibrosis: are they intrinsically defective?” American Journal of Respiratory Cell and Molecular Biology, vol. 46, no. 6, pp. 715–722, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Bals, D. J. Weiner, and J. M. Wilson, “The innate immune system in cystic fibrosis lung disease,” The Journal of Clinical Investigation, vol. 103, no. 3, pp. 303–307, 1999. View at Publisher · View at Google Scholar
  38. M. A. Mall and D. Hartl, “CFTR: cystic fibrosis and beyond,” The European Respiratory Journal, vol. 44, no. 4, pp. 1042–1054, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. Gao, Y. Kang, J. Yu, and L. Ren, “Human pharyngeal microbiome may play a protective role in respiratory tract infections,” Genomics, Proteomics & Bioinformatics, vol. 12, no. 3, pp. 144–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. P. C. Blainey, C. E. Milla, D. N. Cornfield, and S. R. Quake, “Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis,” Science Translational Medicine Logo, vol. 4, no. 153, article 153ra130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Inceoglu, E. F. Hoogwout, P. Hill, and J. D. van Elsas, “Effect of DNA extraction method on the apparent microbial diversity of soil,” Applied and Environmental Microbiology, vol. 76, no. 10, pp. 3378–3382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. N. A. Kennedy, A. W. Walker, S. H. Berry et al., “The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing,” PLoS One, vol. 9, no. 2, article e88982, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Claesson, Q. Wang, O. O’Sullivan et al., “Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions,” Nucleic Acids Research, vol. 38, no. 22, pp. e200–e200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. P. H. Quanjer, S. Stanojevic, T. J. Cole et al., “Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations,” European Respiratory Journal, vol. 40, no. 6, pp. 1324–1343, 2012. View at Publisher · View at Google Scholar · View at Scopus